Genomics is at the heart of precision medicine, enabling the identification of specific genetic mutations responsible for cancer development. By sequencing the genome of cancer cells, researchers can pinpoint mutations that can be targeted with specific drugs. For example, the identification of the BRCA mutations in breast and ovarian cancers has led to the development of PARP inhibitors, which are more effective in patients with these mutations.
